Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue | $10.8M | $14.1M | $16.5M | $22.2M | $30.9M | $44.9M |
| Cost of revenue | $10.0M | $9.4M | $9.7M | $12.2M | $17.0M | $23.3M |
| Gross profit | $785.9K | $4.7M | $6.8M | $10.0M | $14.0M | $21.5M |
| Gross margin | 7.3% | 33.2% | 41.2% | 45.1% | 45.1% | 48.0% |
| R&D | $7.0M | $7.0M | $4.5M | $6.7M | $10.1M | $11.2M |
| Operating income | −$22.9M | −$16.7M | −$13.7M | −$17.9M | −$22.4M | −$18.8M |
| EBITDA | −$21.3M | −$14.7M | −$13.3M | −$14.5M | −$21.8M | −$15.7M |
| Net income | −$24.2M | −$22.4M | −$14.7M | −$17.2M | −$26.5M | −$19.2M |
| Net margin | -223.4% | -158.5% | -89.4% | -77.4% | -85.8% | -42.7% |
| EPS (diluted) | -12.25 | -26.89 | -0.55 | -0.59 | -0.71 | -0.44 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $62M | $-0.35 | $-0.35–$-0.35 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds AUGX.
No tracked institution reports a position in AUGX as of their last filing.
No one on the platform has traded AUGX yet.
| $121M |
| — |
| NEUENeueHealth, Inc. | $6.75 | +0.00% | $61M | — |
| OPNTOpiant Pharmaceuticals, Inc. | $20.65 | +0.00% | $109M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 2.4× sales vs its 3.7× historical median P/S.
Fair value ≈ $3.66 · price $2.35 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$DXST No more single-sector risk — DXST’s AI senior care pivot taps into gov’t-backed aging initiatives in China, plus global expansion potential.    Policy tailwinds + AI innovation = 5-10x upside if adoption ramps, turning this penny into a multi-bagger! Especially at .15 💪 Seems to be a no-brainer. Recent FY2025 sales up 12% to $13M, but this pivot steals the show — AI health could add $20-50M+ annually in a $4T market. From enviro niche to AI health disruptor = re-rate to 3-5x P/S (~$0.50-1.00/share) on execution. Watch for partnerships! 🫡💪 $BNAI $AUGX $CLOV $ATAI
View on StockTwits ↗$DXST is using AI to optimize elderly health monitoring, community services, and wellness — DXST's new platform integrates it all for seamless care. With China's senior market exploding, this could triple DXST's revenue streams beyond enviro services. Bull case: Diversification into high-margin health tech = undervalued gem at ~$3M cap! To date, the platform has generated approximately $1 million in gross transaction volume. $BNAI $AUGX $CLOV $ATAI
View on StockTwits ↗$AUGX where can I buy this stock? I dont see it kn etrade or Fidelity? Please help
View on StockTwits ↗$AUGX I apologize for the confusion, but there is no article provided in the original message. The text states “No content returned” followed by “That was the article.” Without an actual article to work with, I cannot make the requested modifications or output a revised version. https://beyondspx.com/article/augmedix-inc-nasdaq-augx-harnessing-ai-to-transform-medical-documentation
View on StockTwits ↗$AUGX Commure Completes Merger with Augmedix $AUGX
View on StockTwits ↗Time to officially close the Augmedix public story $AUGX
View on StockTwits ↗$AUGX / Commure - Shareholder Vote $AUGX MergerBrief.com Sign Up For Full Schedule
View on StockTwits ↗This $AUGX Go ED solution demo leverages LLMs from $GOOG and $MSFT https://youtu.be/T_h1BT6ejXo?si=XwimJp32Hu2w5Hai
View on StockTwits ↗Dr. Vikesh Tahiliani VP of Care Transformation and Innovation, $HCA Healthcare recently spoke to the multiple "wins" they are experiencing from using $AUGX Go ED. https://www.youtube.com/watch?v=2W_Kr4OvW2o
View on StockTwits ↗$AUGX negotiations for a superior proposal just got juiced up.
View on StockTwits ↗Bulls Charge knocking over Commure’s White Knight position as Takeover Fears and Strategic Exits Crafted in Definitive Deal Spark Speculation of a superior offer to acquire the explosive ambient medical documentation company with a deep tech stack aligned to be a curator of information at the point of care. $AUGX $GOOG $HCA $TDOC $MSFT
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.